Drugs / RO6799477
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02164266 | Jun → Dec 2014 | diabetes mellitus, noninsulin-dependent, 2 | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 1 | NCT01893437 | Jul → Oct 2013 | — | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO6799477 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02164266 ↗ |
| Route | Oral | “Following Oral Administration of Single Ascending Doses in Healthy Volunteers.” NCT01893437 ↗ |